Leukemia, Erythroblastic, Acute - 25 Studies Found Status Study Active, not recruiting Study Name: Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia Condition: Adult Acute Megakaryoblastic Leukemia Adult Acute Monoblastic Leukemia Procedure: Allogeneic Hematopoietic Stem Cell Transplantation Active, not recruiting Study Name: Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia Condition: Adult Acute Megakaryoblastic Leukemia Adult Acute Monoblastic Leukemia Drug: Azacitidine Given IV or Active, not recruiting Study Name: Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders Condition: Adult Acute Megakaryoblastic Leukemia Adult Acute Monoblastic Leukemia Drug: Carboplatin Given IV Completed Study Name: Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase Condition: Adult Acute Basophilic Leukemia Adult Acute Eosinophilic Leukemia Drug: Bortezomib Given IV Completed Study Name: Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia Condition: Adult Acute Basophilic Leukemia Adult Acute Eosinophilic Leukemia